News | August 26, 2009

GE Unveils New Wide Bore 1.5T MRI System

Optima MR450w

August 26, 2009 - GE Healthcare invited a select group of physicians to its Magnetic Resonance Center yesterday in Waukesha, Wisc., to view the company's first wide bore magnetic resonance imaging, the Optima MR450w, a 1.5 Tesla system, that has a 70-cm bore, yet still provides a 50-cm field of view (FOV).

The system serves the needs of the 1 in 5 U.S. patients who are obese or claustrophobic and require a ‘larger’ imaging system. Additionally, Optima MR450w is clinically optimized for specific anatomies, including industry leading breast imaging capabilities, can accommodate more patients with fewer scans and less coaxing for high patient throughput and satisfaction.

The wider bore, says the company, does not compromise image quality. The wider, 50-cm FOV scans more anatomy and the 70-cm wide bore provides enhanced patient comfort. The larger bore is designed to allow greater flexibility for abdominal and extremity imaging, and also allows for two-station spine imaging enabled by the 50-cm FOV.

The patient table holds up to 550 lbs. and has a detachable design to facilitate patient throughput. The advanced capabilities of GE's Discovery platform have been applied in the Optima MR450w for versatility and power.

Built on a fully redesigned MR platform, the Optima MR450w offers applications and capabilities that improve usability as well as providing the following features:

- Condition-Specific Features: Advanced anatomy-optimized capabilities for imaging breast, spine and cardiovascular regions.
- Redesigned Platform Accelerates Image Quality: An exclusive optical RF system and a new 145-cm long magnet offer uniform tissue contrast and optimized MR signal for clean, crisp images
- Patient-Centered Optimization: Exclusive removable table minimizes time between scans while productivity enhancements dramatically reduce time of MR studies

For more information: www.gehealthcare.com

Related Content

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Feature | Contrast Media | July 18, 2019 | By Greg Freiherr
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n
AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
Insightec's Exablate Neuro Approved With GE Signa Premier MRI in U.S. and Europe
News | Focused Ultrasound Therapy | July 10, 2019
GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s...
Delta T1 Maps Provide Quantitative, Automated Solution to Assess Brain Tumor Burden
News | Neuro Imaging | July 05, 2019
Imaging Biometrics LLC (IB) a subsidiary of IQ-AI Ltd., is highlighting a recently published study in the American...
Medic Vision Wins Japanese PMDA Clearance for iQMR Image Reconstruction Solution
News | Magnetic Resonance Imaging (MRI) | July 05, 2019
Medic Vision Imaging Solutions announced that its 3-D iterative image reconstruction technology for shortening magnetic...
LVivo EF Comparable to MRI, Contrast Echo in Assessing Ejection Fraction
News | Cardiovascular Ultrasound | June 19, 2019
DiA Imaging Analysis announced the presentation of two studies assessing the performance and accuracy of the company's...
International Working Group Releases New Multiple Myeloma Imaging Guidelines

X-ray images such as the one on the left fail to indicate many cases of advanced bone destruction caused by multiple myeloma, says the author of new guidelines on imaging for patients with myeloma and related disorders. Image courtesy of Roswell Park Comprehensive Cancer Center.

News | Computed Tomography (CT) | June 17, 2019
An International Myeloma Working Group (IMWG) has developed the first set of new recommendations in 10 years for...
SyMRI Software Receives FDA Clearance for Use With Siemens MRI Systems
Technology | Magnetic Resonance Imaging (MRI) | June 14, 2019
SyntheticMR announced U.S. Food and Drug Administration (FDA) clearance for clinical use of its SyMRI Image and SyMRI...
A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse

Figure 1. A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse from Amsterdam Ph.D. researcher Gustav Strijkers.

News | Magnetic Resonance Imaging (MRI) | June 07, 2019
The Amsterdam University Medical Center has won MR Solutions’ Image of the Year 2019 award for the best molecular...